ReviewCancer discovery2012

Measuring oncogenic signaling pathways in cancer with PET: an emerging paradigm from studies in castration-resistant prostate cancer.

Michael J EvansPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.